SCHEMBL22473722

SCHEMBL22473722

CCC(C)/C=N/N(C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.40
KMT2A Q03164 10/20 0.40
MAPT P10636 9/20 0.40
SMN1; SMN2 Q16637 6/20 0.40
ALDH1A1 P00352 5/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
ALOX12 P18054 2/20 0.40
HPGD P15428 1/20 0.37
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 3/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HCRTR1 O43613 1/20 0.34
TNNI3 P19429 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6960272 0.81 MEN1 (0.44) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL21251507 0.75 MAPT (0.40) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL22473611 0.73 MEN1 (0.44) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL13669995 0.73 MEN1 (0.41) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL28045393 0.70 MEN1 (0.41) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL6979719 0.70 MEN1 (0.47) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL9515353 0.70 MEN1 (0.47) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL12667811 0.70 MEN1 (0.47) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL18648260 0.69 NOS3 (0.36) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL13879231 0.69 MEN1 (0.53) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10787448-B2 Indolizino [3,2-C] quinoline-based fluorescent probe SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2020-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10787448-B2 Indolizino [3,2-C] quinoline-based fluorescent probe DNA2, IRF3, DDB1 MEN1 3101/4885KMT2A 3767/4885MAPT 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.